DTO-FTO trial: Small group quality improvement on prescribing and test ordering performance of general practitioners: a large scale implementation study in the South of the Netherlands
| ISRCTN | ISRCTN40008171 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN40008171 |
| Secondary identifying numbers | NTR1033 |
- Submission date
- 23/08/2007
- Registration date
- 23/08/2007
- Last edited
- 18/04/2017
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr J P Trietsch
Scientific
Scientific
Maastricht University
Department of General Practice
P.O. Box 616
Maastricht
6200 MD
Netherlands
| Phone | +31 (0)43 388 2877 |
|---|---|
| Jasper.Trietsch@HAG.unimaas.nl |
Study information
| Study design | Multicentre cluster-randomised active-controlled parallel-group trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Cluster randomised trial |
| Study setting(s) | GP practice |
| Study type | Treatment |
| Participant information sheet | Not available in web format, please use the contact details to request a patient information sheet |
| Scientific title | DTO-FTO trial: Small group quality improvement on prescribing and test ordering performance of general practitioners: a large scale implementation study in the South of the Netherlands |
| Study objectives | This strategy will improve the number of tests ordered or the volume of prescribed drugs by 20% and decrease the inter-doctor variation. |
| Ethics approval(s) | Ethics Board of the academic hospital Maastricht (azM)/Maastricht University (UM), 24/08/2006, ref: MEC 06-4-033 |
| Health condition(s) or problem(s) studied | Prescribing and test ordering performance of general practitioners |
| Intervention | All participating GP's receive feedback on their own test ordering and prescribing performance in the foregoing six months on a predefined clinical topic. The graphical comparative feedback is send to each GP individually together with an outline of current guidelines on the topic, prior to the group meeting. The feedback will lead to peer review, seeking and discussing explanations for differences, comparing own performance to the guidelines, discussing a plan for change and discussing barriers to change. Each group discusses three clinical topics in six sessions. If the group wishes to do so, two sessions (test ordering and prescribing) can be combined into one session. The intervention will run from September 2007 through February 2009. Please note that as of 05/10/2007, the anticipated start date of this trial was posponed from September 2007 to December 2007. |
| Intervention type | Other |
| Primary outcome measure | 1. The volume of ordered diagnostic tests and of prescribed medication 2. The inter-doctor variation in both test ordering and prescribing Outcomes are measured at start of study (baseline), each 6 months preliminary data, after 18 months main timepoint for effect measurement, 6 and 12 months later long term effect measurement. |
| Secondary outcome measures | 1. The quality of prescribing as defined by indicators 2. The level of functioning of the groups 3. What are the costs of implementation of the strategy? 4. Process data (attendance, altering of the meeting structure etc.) Outcomes are measured at start of study (baseline), each 6 months preliminary data, after 18 months main timepoint for effect measurement, 6 and 12 months later long term effect measurement. |
| Overall study start date | 01/12/2007 |
| Completion date | 01/02/2010 |
Eligibility
| Participant type(s) | Health professional |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 50 groups |
| Key inclusion criteria | Groups of General Practitioners (GPs) conjoint in pharmacotherapeutic audit groups. |
| Key exclusion criteria | 1. Groups of over 15 GP's 2. Groups outside the provinces: Zeeland, Brabant or Limburg |
| Date of first enrolment | 01/12/2007 |
| Date of final enrolment | 01/02/2010 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
Maastricht University
Maastricht
6200 MD
Netherlands
6200 MD
Netherlands
Sponsor information
University Maastricht (UM) (Netherlands)
Hospital/treatment centre
Hospital/treatment centre
Department General Practitioner Medicine
P.O. Box 616
Maastricht
6200 MD
Netherlands
| Phone | +31 (0)43 388 2309 |
|---|---|
| trudy.vanderweijden@hag.unimaas.nl | |
| Website | http://www.unimaas.nl/default.asp?taal=en |
"ROR" |
https://ror.org/02jz4aj89 |
Funders
Funder type
Industry
CZ Health Insurance Company (CZ Actief in Gezondheid) (Netherlands)
No information available
The Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 13/04/2017 | Yes | No |
Editorial Notes
18/04/2017: Publication reference added.
